Source link : https://www.newshealth.biz/health-news/lower-cvd-risk-with-stable-dmard-therapy-in-seropositive-ra/
TOPLINE: The risk for cardiovascular diseases (CVDs) is lower in patients with seropositive rheumatoid arthritis (RA) who remain on stable disease-modifying antirheumatic drug (DMARD) therapy than in those whose treatment regimen is not stable. METHODOLOGY: The risk for CVD in patients with RA is closely associated with increasing levels of systemic inflammation; however, the risk […]
Author : News Health
Publish date : 2024-05-02 04:13:24
Copyright for syndicated content belongs to the linked Source.